(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules...
Stats | |
---|---|
本日の出来高 | 13 758.00 |
平均出来高 | 137 349 |
時価総額 | 141.47M |
EPS | $0 ( 2024-03-01 ) |
次の収益日 | ( $-0.150 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.930 |
ATR14 | $0.00500 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | Vazquez Chris | Buy | 22 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Strobeck Matthew | Buy | 7 392 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Strobeck Matthew | Buy | 1 304 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Schuler Jack W | Buy | 2 174 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Pestano Gary Anthony | Buy | 22 | Series A Non-Voting Convertible Preferred Stock |
INSIDER POWER |
---|
88.87 |
Last 100 transactions |
Buy: 13 131 293 | Sell: 601 205 |
ボリューム 相関
Biodesix, Inc. 相関
10 最も正の相関 | |
---|---|
BNIXU | 0.898 |
HILS | 0.88 |
ENTA | 0.872 |
QNST | 0.861 |
FARO | 0.858 |
BNTX | 0.857 |
SBSI | 0.856 |
DYNT | 0.856 |
CZWI | 0.855 |
KPRX | 0.853 |
10 最も負の相関 | |
---|---|
GPOR | -0.882 |
VRSK | -0.873 |
FTAA | -0.871 |
TBSAU | -0.868 |
NBSTU | -0.868 |
NVSA | -0.868 |
BLDR | -0.868 |
LGTO | -0.868 |
ITQ | -0.868 |
IRMD | -0.868 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Biodesix, Inc. 相関 - 通貨/商品
Biodesix, Inc. 財務諸表
Annual | 2023 |
収益: | $49.09M |
総利益: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2023 |
収益: | $49.09M |
総利益: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2022 |
収益: | $38.21M |
総利益: | $24.06M (62.96 %) |
EPS: | $-1.910 |
FY | 2021 |
収益: | $54.51M |
総利益: | $54.51M (100.00 %) |
EPS: | $-1.580 |
Financial Reports:
No articles found.
Biodesix, Inc.
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。